OMEROS CORP Other Receivables, Net, Current
OMEROS CORP (OMER) had Other Receivables, Net, Current of $111.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:OtherReceivablesNetCurrent · last filed 2026-08-12
- 2026-06-30: Other Receivables, Net, Current $111.00K.
- 2026-03-31: Other Receivables, Net, Current $92.00K.
- 2025-12-31: Other Receivables, Net, Current $750.00K.
- 2025-09-30: Other Receivables, Net, Current $863.00K.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2026-06-30 | $111.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $92.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $750.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $863.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.07M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.45M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $799.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $299.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.27M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $656.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $1.37M 10-K · filed 2025-03-31 |
| 2023-09-30 | $220.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $124.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $302.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $255.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $741.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $810.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $408.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $1.65M 10-K · filed 2023-03-13 |
| 2021-09-30 | $274.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $420.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $250.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $70.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $161.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $86.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $106.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $111.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | $122.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $134.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $138.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $164.00K 10-K · filed 2020-03-02 |
| 2018-09-30 | $132.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $29.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $133.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $65.00K 10-K · filed 2019-03-01 |
| 2016-12-31 | $100.00K 10-K · filed 2018-03-01 |
| 2015-12-31 | $173.00K 10-K · filed 2017-03-16 |
| 2014-12-31 | $68.00K 10-K · filed 2016-03-15 |
| 2013-12-31 | $71.00K 10-K · filed 2015-03-16 |
| 2012-12-31 | $44.00K 10-K · filed 2014-03-13 |
| 2011-12-31 | $14.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |